US Advisory Panel Wants More Data Before Ending Pause on J&J COVID-19 Vaccine
1 sourceUpdated Apr 14, 2021
A U.S. health panel on Wednesday agreed they wanted more data before voting to resume vaccinations with Johnson & Johnson’s COVID-19 shot, even as a U.S. Food and Drug Administration scientist said warnings could…
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
Coverage
Comments
Ask this story anything:
Free account · your comment posts right after signup

